It has been reported that proliferative diseases of the hematopoietic system impact baseline CRP, such as lymphoma induces significantly higher initial CRP levels, while leukemia causes a moderate increase or no effect at all at the same time (Zheng et al., 2024). Here, CRP is linked to leukemia.